For: | Cheng MH, Chiu HF, Ho SC, Tsai SS, Wu TN, Yang CY. Statin use and the risk of colorectal cancer: A population-based case-control study. World J Gastroenterol 2011; 17(47): 5197-5202 [PMID: 22215945 DOI: 10.3748/wjg.v17.i47.5197] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i47/5197.htm |
Number | Citing Articles |
1 |
Naomi Gronich, Gad Rennert. Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates. Nature Reviews Clinical Oncology 2013; 10(11): 625 doi: 10.1038/nrclinonc.2013.169
|
2 |
Ju-Chi Liu, Wen-Rui Hao, Yi-Ping Hsu, Li-Chin Sung, Pai-Feng Kao, Chao-Feng Lin, Alexander T.H. Wu, Kevin Sheng-Po Yuan, Szu-Yuan Wu. Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study. Oncotarget 2016; 7(40): 65270 doi: 10.18632/oncotarget.11263
|
3 |
Natalia Andrushko, Vasyl Andrushko. Stereoselective Synthesis of Drugs and Natural Products. 2013; : 1 doi: 10.1002/9781118596784.ssd029
|
4 |
Baoge Qu, Hao Qu. The Influence of Statins on Risk and Patient Survival in Colorectal Cancer. Journal of Clinical Gastroenterology 2019; 53(9): 699 doi: 10.1097/MCG.0000000000000844
|
5 |
Majken Cardel, Sara M. Jensen, Anton Pottegård, Trine L. Jørgensen, Jesper Hallas. Long‐term use of metformin and colorectal cancer risk in type II diabetics: a population‐based case–control study. Cancer Medicine 2014; 3(5): 1458 doi: 10.1002/cam4.306
|
6 |
Paul Lochhead, Andrew T. Chan. Statins and Colorectal Cancer. Clinical Gastroenterology and Hepatology 2013; 11(2): 109 doi: 10.1016/j.cgh.2012.08.037
|
7 |
Kyung-Soo Chun, Eun-Hee Kim, Sooyeon Lee, Ki Baik Hahm. Chemoprevention of Gastrointestinal Cancer: The Reality and the Dream. Gut and Liver 2013; 7(2): 137 doi: 10.5009/gnl.2013.7.2.137
|
8 |
Amikar Sehdev, Bert H. O’Neil. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer. Current Treatment Options in Oncology 2015; 16(9) doi: 10.1007/s11864-015-0359-z
|
9 |
Wahyu Wulaningsih, Hans Garmo, Lars Holmberg, Niklas Hammar, Ingmar Jungner, Göran Walldius, Mieke Van Hemelrijck. Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study. Journal of Cancer Epidemiology 2012; 2012: 1 doi: 10.1155/2012/792034
|
10 |
Peter S. Liang, Aasma Shaukat, Seth D. Crockett. AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review. Clinical Gastroenterology and Hepatology 2021; 19(7): 1327 doi: 10.1016/j.cgh.2021.02.014
|
11 |
Yanqiong Liu, Weizhong Tang, Jian Wang, Li Xie, Taijie Li, Yu He, Yan Deng, Qiliu Peng, Shan Li, Xue Qin. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes & Control 2014; 25(2): 237 doi: 10.1007/s10552-013-0326-6
|
12 |
Michael Hoffmeister, Lina Jansen, Anja Rudolph, Csaba Toth, Matthias Kloor, Wilfried Roth, Hendrik Bläker, Jenny Chang-Claude, Hermann Brenner. Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment. JNCI: Journal of the National Cancer Institute 2015; 107(6) doi: 10.1093/jnci/djv045
|
13 |
Henry WC Leung, Agnes LF Chan, Daniel Lo, John Hang Leung, Hsiao-Ling Chen. Common cancer risk and statins: a population-based case–control study in a Chinese population. Expert Opinion on Drug Safety 2013; 12(1): 19 doi: 10.1517/14740338.2013.744392
|
14 |
Gemma Ibáñez-Sanz, Elisabet Guinó, Caridad Pontes, Mª Ángeles Quijada-Manuitt, Luisa C de la Peña-Negro, María Aragón, Marga Domínguez, Lorena Rodríguez-Alonso, Alex Blasco, Ana García-Rodríguez, Rosa Morros, Victor Moreno. Statin use and the risk of colorectal cancer in a population-based electronic health records study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49877-5
|
15 |
James Weiquan Li, Malcolm Teck Kiang Tan, Tiing Leong Ang, Eng Kiong Teo. Chemoprevention trials of GI cancers in Asia. Best Practice & Research Clinical Gastroenterology 2015; 29(6): 967 doi: 10.1016/j.bpg.2015.09.014
|